Avalo Therapeutics, Inc. (AVTX): SC 13G/A filed Nov 14, 2024

Form type

SC 13G/A

Filing date

Nov 14, 2024

Accession number

0001013594-24-000957

Filer

Avalo Therapeutics, Inc. (CIK 1534120)